Till startsida
Sitemap
To content Read more about how we use cookies on gu.se

Andreas Josefsson

Researcher

Andreas Josefsson
Researcher
andreas.josefsson@urology.gu.se

Postal Address: Avd för Urologi vid Inst för Kliniska vetenskaper, 51345 Göteborg
Visiting Address: Bruna stråket 11b, vån 2, SU/Sahlgrenska , 41345 Göteborg


Department of Urology at Institute of Clinical Sciences (More Information)
Sahlgrenska Universitetssjukhuset
413 45 Göteborg
0313424145
Visiting Address: Bruna stråket 11b V 2 SU/Sahlgrenska , 413 45 Göteborg

Latest publications

Performance and inter-observer variability of prostate MRI (PI-RADS version 2) outside high-volume centres.
Kimia Kohestani, Jonas Wallström, Niclas Dehlfors, Ole Martin Sponga, Marianne Månsson et al.
Scandinavian journal of urology, Journal article 2019
Journal article

Immunoreactivity for prostate specific antigen and Ki67 differentiates subgroups of prostate cancer related to outcome
P. Hammarsten, Andreas Josefsson, E. Thysell, M. Lundholm, C. Hägglöf et al.
Modern Pathology, Journal article 2019
Journal article

TMPRSS2-ERG Expression Predicts Prostate Cancer Survival and Associates with Stromal Biomarkers
C. Hagglof, P. Hammarsten, K. Stromvall, L. Egevad, Andreas Josefsson et al.
Plos One, Journal article 2014
Journal article

High density of S100A9 positive inflammatory cells in prostate cancer stroma is associated with poor outcome.
Viktor Tidehag, Peter Hammarsten, Lars Egevad, Torvald Granfors, Pär Stattin et al.
European journal of cancer (Oxford, England : 1990), Journal article 2014
Journal article

Tumour epithelial expression levels of endocannabinoid markers modulate the value of endoglin-positive vascular density as a prognostic marker in prostate cancer.
Christopher J Fowler, Andreas Josefsson, Lina Thors, Sui Chu Chung, Peter Hammarsten et al.
Biochimica et biophysica acta, Journal article 2013
Journal article

Nuclear Stat5a/b predicts early recurrence and prostate cancer-specific death in patients treated by radical prostatectomy.
Tuomas Mirtti, Benjamin E Leiby, Junaid Abdulghani, Elina Aaltonen, Miia Pavela et al.
Human pathology, Journal article 2013
Journal article

Showing 1 - 10 of 18

2019

Performance and inter-observer variability of prostate MRI (PI-RADS version 2) outside high-volume centres.
Kimia Kohestani, Jonas Wallström, Niclas Dehlfors, Ole Martin Sponga, Marianne Månsson et al.
Scandinavian journal of urology, Journal article 2019
Journal article

Immunoreactivity for prostate specific antigen and Ki67 differentiates subgroups of prostate cancer related to outcome
P. Hammarsten, Andreas Josefsson, E. Thysell, M. Lundholm, C. Hägglöf et al.
Modern Pathology, Journal article 2019
Journal article

2018

2017

2016

2014

TMPRSS2-ERG Expression Predicts Prostate Cancer Survival and Associates with Stromal Biomarkers
C. Hagglof, P. Hammarsten, K. Stromvall, L. Egevad, Andreas Josefsson et al.
Plos One, Journal article 2014
Journal article

High density of S100A9 positive inflammatory cells in prostate cancer stroma is associated with poor outcome.
Viktor Tidehag, Peter Hammarsten, Lars Egevad, Torvald Granfors, Pär Stattin et al.
European journal of cancer (Oxford, England : 1990), Journal article 2014
Journal article

2013

Tumour epithelial expression levels of endocannabinoid markers modulate the value of endoglin-positive vascular density as a prognostic marker in prostate cancer.
Christopher J Fowler, Andreas Josefsson, Lina Thors, Sui Chu Chung, Peter Hammarsten et al.
Biochimica et biophysica acta, Journal article 2013
Journal article

Nuclear Stat5a/b predicts early recurrence and prostate cancer-specific death in patients treated by radical prostatectomy.
Tuomas Mirtti, Benjamin E Leiby, Junaid Abdulghani, Elina Aaltonen, Miia Pavela et al.
Human pathology, Journal article 2013
Journal article

Showing 1 - 10 of 18

Page Manager: Katarina Olinder Eriksson|Last update: 1/7/2014
Share:

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?